Psoriatic arthritis.

Durham, L E; Taams, L S; Kirkham, B W

Durham, L E; Taams, L S; Kirkham, B W.

Affiliation

Durham LE; Clinical Training Fellow. Centre for Molecular and Cellular Biology of Inflammation, Division of Immunology, Infection and Inflammatory Disease, King's College London, London.
Taams LS; Professor in Immunobiology and head of the Centre for Molecular and Cellular Biology of Inflammation, Division of Immunology, Infection and Inflammatory Disease, King's College London, London.
Kirkham BW; Consultant Rheumatologist in the Department of Rheumatology, Guy's & St Thomas' NHS Foundation Trust, London SE1 9RT.

Br J Hosp Med (Lond) ; 77(7): C102-8, 2016 Jul.

Article in En | MEDLINE | ID: mdl-27388392

Subject(s)

Antirheumatic Agents/therapeutic use; Arthritis, Psoriatic/drug therapy; Adalimumab/therapeutic use; Antibodies, Monoclonal/therapeutic use; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic/diagnosis; Arthritis, Psoriatic/immunology; Certolizumab Pegol/therapeutic use; Etanercept/therapeutic use; Infliximab/therapeutic use; Severity of Illness Index; Ustekinumab/therapeutic use

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Psoriatic / Antirheumatic Agents Type of study: Diagnostic_studies Language: En Journal: Br J Hosp Med (Lond) Journal subject: HOSPITAIS / MEDICINA Year: 2016 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google